Journal: Lipids in Health and Disease
Article Title: High circulating PCSK9 concentration is associated with increased and sex-specific risks of metabolic disease, diabetes mellitus, MASLD, and long-term mortality in a Taiwanese population
doi: 10.1186/s12944-025-02831-z
Figure Lengend Snippet: Participant selection process. Participants were enrolled from the Taiwan Biobank (TWB). Abbreviations: ELISA: enzyme-linked immunosorbent assay; IBD, identity-by-descent; IR, insulin resistance; DM, diabetes mellitus; MetS, metabolic syndrome; CKD, chronic kidney disease; NAFLD, nonalcoholic fatty liver disease; MASLD, metabolic dysfunction–associated steatotic liver disease. *The definition of metabolic dysfunction was shown in Supplementary Fig. 1
Article Snippet: Plasma PCSK9 concentrations were determined using a solid-phase sandwich enzyme-linked immunosorbent assay kit (Human Proprotein Convertase 9/PCSK9 DuoSet ELISA kit; R&D Systems, Minneapolis, MN, USA).
Techniques: Selection, Enzyme-linked Immunosorbent Assay